Scientists have discovered the mechanism which allows the superbug Methicillin Resistant Staphylococcus aureus (MRSA) to become highly resistant to antibiotics, paving the way for new approaches to control infectious disease.
Failed trials for 16 IGF-1R inhibitors and $1.6B later: Time for better preclinical models?
New research published Friday in JAMA Network Open estimates that upwards of $50 billion to $60 billion is spent annually by biopharma companies on failed
August 1, 2023